sexta-feira, 24 de outubro de 2014

Avebarna Courier

New York Times:
Without Lucrative Market, Potential Ebola Vaccine Was Shelved for Years

GALVESTON, Tex. — Almost a decade ago, scientists from Canada and the United States reported that they had created a vaccine that was 100 percent effective in protecting monkeys against the Ebola virus. (...) But experts also acknowledge that the lack of follow-up on such a promising candidate reflects a broader failure to produce medicines and vaccines for diseases that afflict poor countries. Most drug companies have resisted spending the enormous sums needed to to develop products useful mostly to poor countries with little ability to pay for them.

Para ler a íntegra da matéria, clique em